Bernstein lowered the firm’s price target on Moderna (MRNA) to $45 from $55 and keeps a Market Perform rating on the shares. The firm cites the ...

The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...

BRITS are being urged to stay at home and mask up when venturing outside after a “worrying” surge in norovirus cases. While ...

Events built a modular platform for organizers to bring the necessary tools to serve attendees. Their platform allows ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

El debate sobre el papel de las mujeres en los roles de combate, resuelto hace casi una década gracias al éxito en el mundo ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...

Paintings by Ali Akbar Sadeqi are currently on view in an exhibition at Dastan Basement Gallery.  The exhibit will be running ...